Assessment of lactoferrin-conjugated solid lipid nanoparticles for efficient targeting to the lung.

about

Novel surface-engineered solid lipid nanoparticles of rosuvastatin calcium for low-density lipoprotein-receptor targeting: a Quality by Design-driven perspective.

P2860

Q51187401-3073DC0D-0856-418A-9C2A-6C16732AE6C1

P2860

Assessment of lactoferrin-conjugated solid lipid nanoparticles for efficient targeting to the lung.

Item

http://www.wikidata.org/entity/Q49769214

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Assessment of lactoferrin-conj ...... ficient targeting to the lung.

@en

Assessment of lactoferrin-conj ...... ficient targeting to the lung.

@nl

type

Item

label

Assessment of lactoferrin-conj ...... ficient targeting to the lung.

@en

Assessment of lactoferrin-conj ...... ficient targeting to the lung.

@nl

prefLabel

Assessment of lactoferrin-conj ...... ficient targeting to the lung.

@en

Assessment of lactoferrin-conj ...... ficient targeting to the lung.

@nl

P1476

Assessment of lactoferrin-conj ...... ficient targeting to the lung.

@en

P2093

Satish Shilpi

http://www.w3.org/2001/XMLSchema#string

Vandana Soni

http://www.w3.org/2001/XMLSchema#string

Vishnoo Dayal Vimal

http://www.w3.org/2001/XMLSchema#string

P2860

Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel.

Cancer prevention by bovine lactoferrin and underlying mechanisms--a review of experimental and clinical studies.

Ligand-targeted therapeutics in anticancer therapy.

Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications.

The improvement of the anticancer effect of a novel compound benzoic acid, 2-hydroxy-, 2-D-ribofuranosylhydrazide (BHR) loaded in solid lipid nanoparticles

Delivery strategies for sustained drug release in the lungs.

Formation of ion pairing as an alternative to improve encapsulation and anticancer activity of all-trans retinoic acid loaded in solid lipid nanoparticles.

Solid lipid nanoparticles of anticancer drugs against MCF-7 cell line and a murine breast cancer model.

A novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword.

A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung.

P2888

s40204-015-0037-z

P304

55-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40204-015-0037-Z

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276121209

http://www.w3.org/2001/XMLSchema#string

P6179

1040029010

http://www.w3.org/2001/XMLSchema#string

P698

29470795

http://www.w3.org/2001/XMLSchema#string

P921

nanoparticle

P932

5151107

http://www.w3.org/2001/XMLSchema#string

Assessment of lactoferrin-conjugated solid lipid nanoparticles for efficient targeting to the lung.

about

P2860

P2860

Assessment of lactoferrin-conjugated solid lipid nanoparticles for efficient targeting to the lung.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P921

P932